Fig. 5From: Changes in peripheral lymphocyte populations in patients with advanced/recurrent ovarian cancer undergoing splenectomy during cytoreductive surgeryKaplan–Meier analysis of overall survival and progression-free survival in patients who underwent splenectomy (blue) or non-splenectomy (purple) during cytoreductive surgeryBack to article page